Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Ginkgo Bioworks
Ginkgo Bioworks is a leading horizontal platform for cell programming that provides flexible, end-to-end synthetic biology services across diverse markets including food, agriculture,…
Ginkgo Bioworks
Ginkgo Bioworks is a leading horizontal platform for cell programming that provides flexible, end-to-end synthetic biology services across diverse markets including food, agriculture,…
TL;DR
What they do: Horizontal synthetic biology platform providing end-to-end cell programming, automated foundries, software, and data products
Headquarters / origin: Boston; founded out of MIT in 2008
Scale: Large R&D platform (~$1B R&D platform) and hundreds of employees
Funding: Raised >$1.5B total (includes public / SPAC proceeds)
Company Overview
Problem Domain
Synthetic biology / bioengineering for applications across agriculture, food, pharmaceuticals, industrial chemicals, and biosecurity.
Founded
2008
Industry
Biotechnology / Synthetic Biology
Tech Stack
Funding Track Record
275000000.00
Series D announced to support build-out of production facility; participating investors included Viking Global and others.
290000000.00
Series E reported in 2019; brought total private funding prior to IPO to roughly $719M.
Completed a public listing via a SPAC in September 2021; transaction valued the company in the public markets.
Investor Signal
“Viking Global, YC Continuity Fund, Cascade Investment, General Atlantic, Baillie Gifford, Senator Investment Group”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week